Literature DB >> 17349449

Development of a risk score for colorectal cancer in men.

Jane A Driver1, J Michael Gaziano, Rebecca P Gelber, I-Min Lee, Julie E Buring, Tobias Kurth.   

Abstract

BACKGROUND: Colorectal cancer is a common and preventable disease for which screening rates remain unacceptably low.
METHODS: We developed a risk scoring system for the development of colorectal cancer among participants in the Physician's Health Study, a prospective cohort of 21,581 US male physicians who were all free of cancer. Predictors of colorectal cancer were self-reported and identified from the baseline questionnaire. Logistic regression was used to determine the independent predictors of incident colorectal cancer over the follow-up period. Risk scores were created from the sum of the odds ratios of the final predictors and used to divide the cohort into categories of increasing relative risk.
RESULTS: During 20 years of follow-up, 381 cases of colon cancer and 104 cases of rectal cancer developed in the cohort. Age, alcohol use, smoking status, and body mass index were independent significant predictors of colorectal cancer. The point scores were used to define 10 risk groups. Those in the highest risk group (9-10 points) had an odds ratio of 15.29 (6.19-37.81) for colorectal cancer compared with those with the lowest risk. We further stratified scores into 3 risk classes. Compared with those at the lowest relative risk, the odds ratio for colorectal cancer was 3.07 (2.46-3.83) in the intermediate risk group and 5.75 (4.44-7.44) in the highest risk group.
CONCLUSIONS: We developed a simple scoring system for colorectal cancer that identifies men at increased relative risk on the basis of age and modifiable factors. This tool should be validated in other populations.

Entities:  

Mesh:

Year:  2007        PMID: 17349449     DOI: 10.1016/j.amjmed.2006.05.055

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  52 in total

1.  The impact of stratifying by family history in colorectal cancer screening programs.

Authors:  Simon Lucas Goede; Linda Rabeneck; Iris Lansdorp-Vogelaar; Ann G Zauber; Lawrence F Paszat; Jeffrey S Hoch; Jean H E Yong; Frank van Hees; Jill Tinmouth; Marjolein van Ballegooijen
Journal:  Int J Cancer       Date:  2015-02-20       Impact factor: 7.396

2.  Does one pill a day keep the colonoscopist away?

Authors:  Alaa Rostom; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

Review 3.  Do recent epidemiologic observations impact who and how we should screen for CRC?

Authors:  Ethan Bortniker; Joseph C Anderson
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

4.  Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.

Authors:  Kana Wu; Edward L Giovannucci; Yin Cao; Bernard A Rosner; Jing Ma; Rulla M Tamimi; Andrew T Chan; Charles S Fuchs
Journal:  Int J Cancer       Date:  2015-04-23       Impact factor: 7.396

5.  Association between meeting the WCRF/AICR cancer prevention recommendations and colorectal cancer incidence: results from the VITAL cohort.

Authors:  Theresa A Hastert; Emily White
Journal:  Cancer Causes Control       Date:  2016-10-17       Impact factor: 2.506

6.  Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study.

Authors:  Helene Kirkegaard; Nina Føns Johnsen; Jane Christensen; Kirsten Frederiksen; Kim Overvad; Anne Tjønneland
Journal:  BMJ       Date:  2010-10-26

7.  Lifestyle factors and their combined impact on the risk of colorectal polyps.

Authors:  Zhenming Fu; Martha J Shrubsole; Walter E Smalley; Huiyun Wu; Zhi Chen; Yu Shyr; Reid M Ness; Wei Zheng
Journal:  Am J Epidemiol       Date:  2012-10-18       Impact factor: 4.897

8.  Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.

Authors:  Thomas F Imperiale; Patrick O Monahan; Timothy E Stump; Elizabeth A Glowinski; David F Ransohoff
Journal:  Ann Intern Med       Date:  2015-09-01       Impact factor: 25.391

9.  Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index.

Authors:  Li-Li Xing; Zhen-Ning Wang; Li Jiang; Yong Zhang; Ying-Ying Xu; Juan Li; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

10.  The diagnosis of colorectal cancer in patients with symptoms: finding a needle in a haystack.

Authors:  Robert H Fletcher
Journal:  BMC Med       Date:  2009-04-17       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.